NextPlat Corp NXPL revenue by segment, product and geography
In its fiscal year ending 2025-12-31, NextPlat Corp reported revenue across 2 business segments; the largest, Healthcare Operations, was $39.7M, 73.1% of the filed sum (-24.1% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Healthcare Operations$39.7M73.1%-24.1% yoy
- Ecommerce Revenue$14.6M26.9%+5.9% yoy
Members sum to the consolidated $54.3M for this period.
- Product$49.7Mshare n/a-10.6% yoy
- Pharmacy Prescription And Other Revenue Net Of Pbm Fees$35.7Mshare n/a-14.8% yoy
- Ecommerce Revenue$14.6Mshare n/a+5.9% yoy
- Service$4.66Mshare n/a-55.8% yoy
- Pharmacy340b Contract$4.01Mshare n/a-61.4% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Healthcare Operations$6.66M67.5%-39.0% yoy
- Ecommerce Revenue$3.2M32.5%+6.4% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.